Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain (Q34559496)

3 August 2017

title

Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain (English)

1 reference

3 August 2017

1 reference

Haruhiko Hiraoka

1

1 reference

3 August 2017

Koujirou Yamamoto

2

1 reference

3 August 2017

Soutarou Miyoshi

3

1 reference

3 August 2017

Toshihiro Morita

4

1 reference

3 August 2017

Katsunori Nakamura

5

1 reference

3 August 2017

Yuuji Kadoi

6

1 reference

3 August 2017

Fumio Kunimoto

7

1 reference

3 August 2017

Ryuya Horiuchi

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

British Journal of Clinical Pharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

60

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

176-182

1 reference

Propofol metabolites in man following propofol induction and maintenance

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Involvement of human liver cytochrome P4502B6 in the metabolism of propofol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

The role of human lungs in the biotransformation of propofol.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Population pharmacokinetics of propofol: a multicenter study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Formulation-dependent brain and lung distribution kinetics of propofol in rats

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Pulmonary uptake of propofol in cats. Effect of fentanyl and halothane.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Fentanyl and propofol uptake by the lung: effect of time between injections.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Disposition of propofol administered as constant rate intravenous infusions in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Pharmacokinetics and protein binding of propofol in patients with cirrhosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Pharmacokinetics of propofol administered by continuous infusion in patients with cirrhosis. Preliminary results.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Pharmacokinetics of propofol infusions in patients with cirrhosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Propofol metabolism in man during the anhepatic and reperfusion phases of liver transplantation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Pharmacokinetics of propofol and haemodynamic changes during induction of anaesthesia in uraemic patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Improving the clinical utility of anesthetic drug pharmacokinetics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02393.X

Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02393.X

Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. The Multicenter Study of Perioperative Ischemia Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02393.X

First-pass lung uptake and pulmonary clearance of propofol: assessment with a recirculatory indocyanine green pharmacokinetic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02393.X

Pulmonary disposition of propofol in surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02393.X

Drug glucuronidation by human renal UDP-glucuronosyltransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02393.X

Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02393.X

Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2005.02393.X

Propofol concentrations during the anhepatic phase of living-related donor liver transplantation

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Subcellular expression of UGT1A6 and CYP1A1 responsible for propofol metabolism in human brain.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Hepatosplanchnic oxygenation is better preserved during mild hypothermic than during normothermic cardiopulmonary bypass.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Use of proton nmr spectroscopy to measure propofol metabolites in the urine of the female Caucasian patient.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884930

Physiological parameters in laboratory animals and humans

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16042671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Superior hepatic mitochondrial oxidation-reduction state in normothermic cardiopulmonary bypass.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16042671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2005.02393.X

1 reference

3 August 2017

1 reference

3 August 2017

1 reference